289 related articles for article (PubMed ID: 29256046)
1. Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.
Baratto L; Jadvar H; Iagaru A
Mol Imaging Biol; 2018 Aug; 20(4):501-509. PubMed ID: 29256046
[TBL] [Abstract][Full Text] [Related]
2. Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in Oncology.
Maina T; Nock BA; Kulkarni H; Singh A; Baum RP
PET Clin; 2017 Jul; 12(3):297-309. PubMed ID: 28576168
[TBL] [Abstract][Full Text] [Related]
3. From Bench to Bed: New Gastrin-Releasing Peptide Receptor-Directed Radioligands and Their Use in Prostate Cancer.
Maina T; Nock BA
PET Clin; 2017 Apr; 12(2):205-217. PubMed ID: 28267454
[TBL] [Abstract][Full Text] [Related]
4. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
[TBL] [Abstract][Full Text] [Related]
5. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.
Maina T; Bergsma H; Kulkarni HR; Mueller D; Charalambidis D; Krenning EP; Nock BA; de Jong M; Baum RP
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):964-973. PubMed ID: 26631238
[TBL] [Abstract][Full Text] [Related]
6. Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives.
Gorica J; De Feo MS; Filippi L; Frantellizzi V; Schillaci O; De Vincentis G
Expert Rev Mol Diagn; 2022 Nov; 22(11):991-996. PubMed ID: 36369779
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
8. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
9. An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting.
Yu Z; Ananias HJ; Carlucci G; Hoving HD; Helfrich W; Dierckx RA; Wang F; de Jong IJ; Elsinga PH
Curr Pharm Des; 2013; 19(18):3329-41. PubMed ID: 23431995
[TBL] [Abstract][Full Text] [Related]
10. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years.
Dalm S; Duan H; Iagaru A
PET Clin; 2024 Jul; 19(3):401-415. PubMed ID: 38644111
[TBL] [Abstract][Full Text] [Related]
11. GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals.
Kurth J; Potratz M; Heuschkel M; Krause BJ; Schwarzenböck SM
Nuklearmedizin; 2022 Jun; 61(3):247-261. PubMed ID: 35668669
[TBL] [Abstract][Full Text] [Related]
12. Investigation of bombesin peptide as a targeting ligand for the gastrin releasing peptide (GRP) receptor.
Begum AA; Moyle PM; Toth I
Bioorg Med Chem; 2016 Nov; 24(22):5834-5841. PubMed ID: 27670095
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
Lim JC; Cho EH; Kim JJ; Choi SM; Lee SY; Nam SS; Park UJ; Park SH
Nucl Med Biol; 2015 Mar; 42(3):234-41. PubMed ID: 25498002
[TBL] [Abstract][Full Text] [Related]
14. Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor.
Rurarz BP; Bukowczyk M; Gibka N; Piastowska-Ciesielska AW; Karczmarczyk U; Ulański P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834867
[TBL] [Abstract][Full Text] [Related]
15. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
[TBL] [Abstract][Full Text] [Related]
16. Toward the Optimization of Bombesin-Based Radiotracers for Tumor Targeting.
Valverde IE; Vomstein S; Mindt TL
J Med Chem; 2016 Apr; 59(8):3867-77. PubMed ID: 27054526
[TBL] [Abstract][Full Text] [Related]
17. GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs.
Carlucci G; Kuipers A; Ananias HJ; de Paula Faria D; Dierckx RA; Helfrich W; Rink R; Moll GN; de Jong IJ; Elsinga PH
Peptides; 2015 May; 67():45-54. PubMed ID: 25797109
[TBL] [Abstract][Full Text] [Related]
18. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
[TBL] [Abstract][Full Text] [Related]
19. Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy.
Peng S; Zhan Y; Zhang D; Ren L; Chen A; Chen ZF; Zhang H
Proc Natl Acad Sci U S A; 2023 Feb; 120(6):e2216230120. PubMed ID: 36724251
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the new GRPR-antagonist
Lymperis E; Kaloudi A; Kanellopoulos P; Krenning EP; de Jong M; Maina T; Nock BA
J Labelled Comp Radiopharm; 2019 Aug; 62(10):646-655. PubMed ID: 30963606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
